Gujarat Themis Biosyn Limited logo

GUJTHEM

NSE
Gujarat Themis Biosyn Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
378.95
4.40 (1.17%)
High VOLATILITY
As on 10 Jul 2026

Price History

Market Cap
₹4.13K Cr
SMALL CAP
P/E Ratio
87.4
Industry
Pharmaceuticals
52-Week Range
52W Low225.05+68.4%
52W High479-20.9%
Current Price
378.95
Circuit Limits (20%)
Lower Circuit303.16
Upper Circuit454.74
Reference Price
378.95

Investment Checklist

10/20 Bearish Cross detected 2 day(s) ago
EMA(50) Crossover: Price crossed above EMA(50): Fresh bullish momentum signal.
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Fundamental score 54 — strong financial health

Technical Analysis

Technical Analysis

Analysis from 2026-07-10

Confidence
46%

Trend

NEUTRAL
NEUTRAL

Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)

EMA20
384.73
EMA50
375.41
EMA200
370.77

Price Action

MIXED
NEUTRAL
Higher Highs5
Higher Lows4
Lower Highs4
Lower Lows5

Support & Resistance Levels

Resistance (Above)
403.48
412.38
424.90
434.25
441.20
Support (Below)
378.75
371.45
362.65
353.88
338.96

Volume Analysis

TrendDECREASING
Change-57.00%
Unusual VolumeNo

Recent MA Crossovers

10/20 Bearish Cross
2 days ago
SELL

Stop Loss Levels

Fixed Risk

1% Risk375.16
3% Risk367.58
5% Risk360.00
7% Risk (Custom)
352.42

Technical Levels

1x ATR (Volatility)362.30
2x ATR (Swing)345.65
3x ATR (Trend)329.00
Immediate Support378.75

Moving Averages

EMA 50 (Trend)375.41
EMA 200 (Long-term)370.77

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹37.7 Cr₹35.9 Cr₹42.3 Cr₹43.4 Cr
Net Profit₹12 Cr₹9.1 Cr₹14.3 Cr₹12.5 Cr
EPS₹0.83₹1.31₹1.14
Operating Profit₹17.3 Cr₹14.2 Cr₹21.8 Cr₹21.7 Cr
ROE
19.64%
ROCE
23.73%
Debt/Equity
0.12
Current Ratio
2.53
OPM
50.09%
NPM
28.74%

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol
Name
Price
Change
P/E Ratio
Market Cap
Sun Pharmaceutical Industries Limited₹1,935.50-0.17%40.2
₹4.64L Cr
Divi's Laboratories Limited₹6,836.00+0.34%70.4
₹1.81L Cr
Torrent Pharmaceuticals Limited₹4,901.50+0.07%77.5
₹1.66L Cr
Cipla Limited₹1,439.40-0.13%30.1
₹1.16L Cr
Zydus Lifesciences Limited₹1,150.80-0.71%23.0
₹1.16L Cr
Lupin Limited₹2,496.30-0.28%21.4
₹1.14L Cr
Mankind Pharma Limited₹2,525.10-0.27%54.3
₹1.04L Cr
Dr. Reddy's Laboratories Limited₹1,244.30-1.99%25.6
₹1.04L Cr
Aurobindo Pharma Limited₹1,564.70-1.43%26.1
₹90.88K Cr
Laurus Labs Limited₹1,537.80+2.02%91.5
₹83.02K Cr
Gujarat Themis Biosyn Limited₹378.95+1.17%87.4
₹4.13K Cr

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
04 Sept 2025
Dividend - Re 0.67 Per Share
DIVIDEND

Announcements

Latest updates

View All
DateDescriptionLink
10 Jul 2026
Shareholders meeting
10 Jul 2026
Shareholders meeting
10 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Jul 2026
Shareholders meeting
10 Jul 2026
Shareholders meeting

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
19 Jun 2026
Board meeting Rescheduled
19 Jun 2026
Board Meeting Intimation
19 Jun 2026
Fund Raising
06 Jun 2026
Board Meeting Intimation
06 Jun 2026
Fund Raising/Other business matters

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025Pledged: 4.49%

Current Distribution

Trend (Last 4 Qtrs)

Latest News

News for GUJTHEM

View All
NEWS
positive
Business Standard - Markets 47d ago

Gujarat Themis Biosyn jumps on acquisition of Japan-based MicroBiopharm

Gujarat Themis Biosyn surged 6.11% to Rs 391.40 after the company announced the acquisition of Japan-based MicroBiopharm Japan Co. (MBJ) for about JPY 21.5 billion, or nearly Rs 1,300 crore.

GUJTHEMHealthcare
Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore
positive
CNBC TV18 - Markets 49d ago

Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore

Shares of Gujarat Themis Biosyn Ltd ended at ₹364.50, up by ₹7.40, or 2.07%, on the BSE.

BSEGUJTHEMFinancial ServicesHealthcare
Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma, Hindalco, Eicher Motors, Divis Labs, NTPC in focus on 25 May
positive
Moneycontrol NaNd ago

Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma, Hindalco, Eicher Motors, Divis Labs, NTPC in focus on 25 May

Stocks to Watch, 25 May: Stocks like NTPC, Hindalco Industries, Eicher Motors, Torrent Pharmaceuticals, Colgate Palmolive India, Divis Laboratories, Tata Capital, Lenskart Solutions, LG Electronics, Meesho, ICICI Prudential AMC, and Billionbrains Garage Ventures Groww will be in focus on May 28.

AKCAPITALPL30IETFAUTOIETFBANKIETFBSE500IETFCASHIETFCOLPALCOMMOIETFCONSUMIETFCPCAPEICHERMOTEVIETFEXIDEINDFINIETFFMCGIETFFOCUSGLENMARKGOLDIETFGROWWGROWWCAPMGSEC10IETFGSEC5IETFGUJTHEMHEALTHIETFHINDALCOICICIAMCICICIB22ICICIPRULIINFRAIETFITIETFLENSKARTLGEINDIALIQUIDIETFLOWVOLIETFMEESHOMETALIETFMIDCAPIETFMIDSELIETFMOM30IETFNEXT50IETFNIF100IETFNIFTYIETFNTPCNV20IETFOILIETFPSUBNKIETFPVTBANIETFQUAL30IETFSENSEXIETFSILVERIETFTATACAPTATATECHTMCVTMPVTOP15IETFTORNTPHARMTVSELECTTVSHLTDTVSMOTORVAL30IETFAutomobile and Auto ComponentsCapital Goods

Frequently Asked Questions